Peter Noseworthy, M.D. is an associate professor of Medicine and a cardiac electrophysiologist specializing in catheter ablation of cardiac arrhythmias. He serves as the director of the Mayo Clinic Heart Rhythm and Physiologic Monitoring Laboratory. He is active in several professional societies and lectures nationally and internationally on the management of patients with cardiac arrhythmia, particularly atrial fibrillation. He joined the Mayo Clinic faculty in 2013 after completing his internal medicine, cardiology, chief residency, and electrophysiology training at Massachusetts General Hospital in Boston. His clinical practice focuses on the management of atrial fibrillation, ventricular tachycardia, and the supraventricular arrhythmias.
Dr. Noseworthy’s research efforts are centered on improving the care of patients with cardiac arrhythmias. He has a concurrent role in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery where he works with the Optum Labs Data Warehouse dataset to examine outcomes in patients with various heart rhythm disorders, particularly the prevention of stroke related to atrial fibrillation. He is also working to identify genetic determinants of ventricular arrhythmia, develop noninvasive means for arrhythmia risk stratification, refine catheter-based ablation techniques, and evaluate the approach to shared decision making in cardiology. His current research is funded by both intramural and federal grants.